In addition, Dyrk1B inhibition by RO5454948 sensitized the pancreatic cancer cell lines Panc1 and SU86.86 to gemcitabine, as well as the colorectal cancer cell line SW620 to cisplatin [59]. The gene discussed is DYRK1B; the disease is pancreatic neoplasm.